Engflag

Cloralex

Quick links to important sections

Cloralex

There is no image.

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cloralex

What is Cloralex?

Cloralex is a pharmacological agent primarily classified as a sedative-hypnotic. It is a formulation of chloral hydrate, a compound that has been utilized in clinical practice for its ability to induce sleep and provide sedation. Unlike many modern sedatives that belong to the benzodiazepine or non-benzodiazepine classes, Cloralex belongs to an older category of medications known as chlorinated hydrocarbons.

Mechanism and Purpose

The primary function of Cloralex is to depress the central nervous system. When the body metabolizes chloral hydrate, it is converted into an active metabolite which acts on the brain to produce a calming effect. This process helps to reduce the time it takes to fall asleep and can be used to manage short-term insomnia or to provide sedation before certain medical procedures.

Characteristics

Cloralex is characterized by its specific chemical structure and its history as one of the earliest synthetic sedative agents. It is typically utilized when other first-line treatments are not suitable or when a specific type of sedation is required for clinical observation. The medication focuses on providing a temporary physiological shift to facilitate rest without the prolonged muscle-relaxant properties associated with other sedative classes.

What side effects are possible with Cloralex?

The official safety profile of clorazepate dipotassium is defined by its activity as a central nervous system (CNS) depressant, leading to a range of officially documented adverse reactions primarily affecting neurological functions.

Frequency and System Classification

The most frequently reported adverse reactions are generally classified as Common in regulatory documentation. These include CNS effects such as drowsiness, dizziness, fatigue, and problems with coordination (ataxia). Less common reactions documented in labeling span other system-organ classes, including Gastrointestinal Disorders (e.g., dry mouth, constipation) and Eye Disorders (e.g., blurred vision, diplopia).

Serious Safety Considerations

Regulatory documents highlight the potential for serious adverse reactions. These include the possibility of paradoxical reactions—adverse psychological effects such as agitation, excitement, or hallucinations. Use is also associated with the risk of developing physical and psychological dependence, particularly with prolonged exposure. The official labeling states that the medication is contraindicated in patients with severe hepatic (liver) impairment, severe respiratory insufficiency, and a history of hypersensitivity to benzodiazepines.

Time-Related and Population-Specific Patterns

Certain safety patterns are linked to the timing of use. CNS depressant effects are typically noted as being most prominent at the initiation of treatment or following a dose adjustment. The risk of dependence and subsequent withdrawal symptoms upon cessation is a recognized safety pattern associated with long-term use. Furthermore, specific population considerations apply: older adults may exhibit greater sensitivity to the CNS effects, and patients with renal or hepatic impairment require particular attention.

Overdose and Emergency Response

Overdosage with Cloralex (clorazepate dipotassium) involves a spectrum of Central Nervous System (CNS) depression, as documented in official regulatory prescribing information. The clinical manifestations are typically grouped by severity. Symptoms in milder cases include drowsiness, lethargy, confusion, slurred speech, and impaired coordination (ataxia). More serious presentations may involve hypotonia and hypotension.

Severe outcomes can rapidly escalate to profound sedation, respiratory depression, coma, and, rarely, death. The risk of these life-threatening events is significantly elevated when the drug is co-ingested with other CNS depressants, particularly alcohol or opioids. Elderly and very young patients are specifically noted in regulatory documents as having increased susceptibility to severe CNS effects.

Immediate medical attention or contact with emergency services is required if severe manifestations, such as trouble breathing, collapse, or unresponsiveness, are observed. The official management approach is symptomatic and supportive, emphasizing the monitoring of respiratory and cardiovascular functions. Although the antagonist flumazenil is available, its use is cautioned against in physically dependent individuals due to the documented risk of precipitating acute withdrawal reactions.

Therapeutic Uses of Cloralex

What Cloralex Treats: Main Uses and Benefits

The therapeutic role of Cloralex (clorazepate dipotassium) is generally applied across domains where additional symptomatic support is needed, assisting with the overall symptom burden linked to heightened physiological activity. This medication is considered relevant in clinical settings marked by increased discomfort or tension. The medicine is used for managing anxiety disorders, providing short-term relief of acute alcohol withdrawal, and serving as an accompanying (adjunct) treatment for partial seizures.

Cloralex is commonly used to help with the management of pronounced anxiety, targeting symptom clusters that may become intense or disruptive, such as excessive worry and apprehension. It provides support that helps ease the overall symptom burden of psychological tension, which contributes to improved comfort and stability when symptoms interfere with daily functioning. Applied during phases of increased distress or discomfort, the medication supports clinical stabilization and temporary assistance in symptom management during acute withdrawal episodes.

In the context of partial seizures, this application is used to address symptoms that create noticeable functional strain, which may assist with helping patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.

Quick Fact: Support for Symptoms of Tension and Agitation

Eligibility and Restrictions for Use

Cloralex is a brand name for a sodium hypochlorite solution primarily marketed as a household disinfectant. It is not regulated as a human-use pharmaceutical drug by major agencies like the U.S. FDA or the EMA, meaning it does not have an official drug prescribing information (PI) or Summary of Product Characteristics (SmPC).

However, the active ingredient, sodium hypochlorite, is officially recognized in lower concentrations for therapeutic use as a Topical Antiseptic Solution (e.g., Dakin's Solution). The eligibility criteria for this therapeutic preparation define who can and cannot use the compound, based on official regulatory documentation.

Eligibility Constraints for Therapeutic Sodium Hypochlorite

Population Category Regulatory Status
Use is Contraindicated Individuals with a known hypersensitivity or allergy to chlorine products.
Restricted/Prohibited Route Must be used for external, topical application only; internal use is prohibited.
Use Not Established Pediatric populations (due to lack of specific safety and efficacy data).
Pregnancy/Lactation Classified as Pregnancy Category C; use is not definitively established as safe.

These constraints define the official eligibility profile by formally prohibiting use in allergic individuals and limiting application to the topical route, with restricted status for pediatric, pregnant, and breastfeeding patients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for clorazepate dipotassium is defined by specific effects when co-administered with other products. The most significant concern is pharmacodynamic reinforcement with Central Nervous System (CNS) depressants. Co-administration with Opioids carries a formal regulatory warning due to the severe risk of profound sedation, respiratory depression, coma, and death. The use of other CNS depressants, such as antipsychotics or sedatives, is advised against as this may lead to an enhancement of central depressive effects. A substance interaction is documented with alcohol (ethanol), where co-ingestion is not recommended due to the potential for increased sedative effects.

Metabolic and Exposure-Altering Interactions

Pharmacokinetic interactions involve the active metabolite, nordiazepam, and hepatic enzymes. Co-administration with certain CYP3A4 Inhibitors can officially increase the serum concentration of the active metabolite by reducing metabolic clearance. Conversely, CYP3A4 Inducers may result in a decrease in the level or effect of the drug by accelerating clearance.

Other Interaction Considerations

As the drug is classified as an Antiepileptic Drug (AED), co-use with other AEDs is associated with a shared, documented risk of an increase in suicidal thoughts or behavior. Finally, in patient populations with impaired hepatic or renal function, the drug's effects may be increased because of slower physiological removal from the body, necessitating usual precautions.

Mechanism of Action

Non-Selective Oxidation of Microbial Macromolecules

The core mechanism involves the action of the oxidizing species, hypochlorous acid ( HOCl), which is formed from sodium hypochlorite in solution. This species is highly reactive and non-selectively targets and penetrates microbial cells (bacteria, viruses, fungi), rapidly oxidizing and denaturing essential proteins, enzymes, and lipids within their structure. This immediate, irreversible chemical damage directly prevents critical metabolic functions and destroys the structural integrity of the cell membrane, resulting in the biocidal destruction of microorganisms.

Cascade of Cellular Destruction and Widespread Biocidal Effect

Cloralex initiates a rapid cascade of simultaneous cellular failures. The oxidation of sulfhydryl groups ( -SH) halts enzyme activity necessary for energy production and metabolism, while lipid degradation causes the cell membrane to dissolve. This multi-pronged attack compromises the pathogen's ability to repair itself or maintain homeostasis, resulting in cell lysis and death across a broad spectrum of microorganisms. This destructive cascade contributes to the compound's profile of broad-spectrum biocidal activity.

Dosage and Administration Information

How to Use Cloralex

Cloralex (clorazepate dipotassium) is an oral medication that must be used strictly according to established procedures and dosage limits. This section outlines the instructions for administration and dosing.

Administration and Dosing Parameters

Usage Parameter Instructions
Route of Administration Oral. Tablets or capsules must be swallowed whole as directed.
Dosing Frequency The total daily dose may be taken once daily (often at bedtime) or in divided doses throughout the day.
Anxiety Dosing Range Initial dose is typically 15 mg daily. The maintenance range is generally 15 mg to 60 mg per day.
Seizure Dosing For adjunctive treatment of partial seizures, the initial adult dose is 7.5 mg three times daily, not exceeding 90 mg/day

Procedural Rules and Duration

Course Duration: For the management of anxiety disorders, the duration of use is generally considered short-term, with clinical usefulness documented for up to 4 months.

Dose Adjustment: Dosage adjustments must be made gradually and are individualized based on patient need. The entire course of therapy should be kept to the shortest effective duration possible.

Specific Populations:

  • Older Adults (Geriatric): Treatment should be initiated at the low end of the dosing range (e.g., 7.5 mg to 15 mg daily) due to increased sensitivity.
  • Discontinuation: The medication must not be stopped suddenly. A protocol of gradual dose tapering is required when discontinuing Cloralex to minimize potential procedural issues.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cloralex

The available information on Cloralex (clorazepate dipotassium) is derived from clinical research, including controlled studies and trials. This research was studied for its use in three main approved contexts: anxiety disorders, symptomatic relief in acute alcohol withdrawal, and use as an add-on treatment for partial seizures. The findings describe patterns observed in patient groups and help contextualize the overall evidence landscape.

Evidence for use in Research Contexts for Anxiety Disorders

Research on Cloralex for anxiety has primarily used short-term Controlled Clinical Trials. These studies explored the effects of Cloralex in patients with anxiety disorders and documented changes in symptoms over a limited time frame. Researchers monitored outcomes related to psychological tension and overall patient-reported comfort, using standardized rating scales to measure changes in symptom intensity.

The findings describe patterns observed in the studies. Research highlights that systematic follow-up in the studies generally did not extend beyond four months. Reports on the use of Cloralex contribute to the understanding of how symptoms evolved in the observed populations during the study period. However, data remains limited for the study of long-term outcomes for anxiety, as systematic clinical studies have not been conducted for durations greater than four months.

Evidence for use in Studies of Acute Alcohol Withdrawal

Cloralex was studied for its use in contexts where symptomatic relief was the primary goal during acute alcohol withdrawal. The evidence is derived from Clinical Studies conducted with adult patients admitted to treatment units, focusing on the very short initial phase of withdrawal.

Evidence for use in Adjunct Therapy Studies for Partial Seizures

Cloralex was evaluated as an add-on (adjunct) treatment for managing partial seizures in individuals already taking other anti-epileptic medications. Long-term Clinical Studies and Adjunctive Therapy Trials were used to explore the effects in adults and children (ages nine and older). Studies primarily monitored the measurement of changes in seizure frequency over time. Limited data exists regarding its use as a sole treatment.

Frequently Asked Questions (FAQ)

Common questions about Cloralex (FAQ)

Q: How quickly does Cloralex usually start to work?

Cloralex is a prodrug, meaning the body first converts it into its active form, nordiazepam. This active substance typically reaches its highest concentration in the body in approximately one to two hours after the dose. This time frame provides an indication of when the active form reaches its peak concentration.

Q: How long do the effects of one dose of Cloralex typically last?

The active substance derived from Cloralex is known to have a long elimination half-life. Official information indicates this half-life typically ranges from 30 to 100 hours. This long half-life indicates the drug remains in the system for an extended period after use.

Q: Are there any serious or rare side effects associated with Cloralex?

Official warnings describe the potential for serious effects, including the risk of physical and psychological dependence, particularly with long-term use. There is also a risk of paradoxical reactions, which are adverse psychological effects like agitation or excitement. When used with certain medications classified as CNS depressants, there is a regulatory warning regarding the risk of respiratory depression.

Q: Can people with liver problems use Cloralex?

Regulatory information states that use is contraindicated (prohibited) for patients with severe hepatic (liver) impairment. For patients with less severe liver problems, official texts indicate that the drug's clearance from the body may be reduced. Any consideration of use in patients with liver conditions requires specific healthcare provider guidance.

Q: Does having kidney issues mean I can't take Cloralex?

Regulatory documents recommend that patients with impaired renal (kidney) function be treated with caution. This is because the physiological removal of the drug from the body may be slower than usual, potentially increasing its effects on the body.

Q: Can I split or crush the Cloralex pill if it is hard to swallow?

No. The official instructions for administration state that tablets or capsules must be swallowed whole as directed. This is required to ensure the medication's intended administration and absorption profile.

Q: Where can I find the official prescribing information or patient leaflet for Cloralex?

Official drug documentation, such as the U.S. Food and Drug Administration (FDA) Prescribing Information and the patient leaflet, is publicly published and maintained by government drug agencies like the NIH DailyMed. This information can also be obtained directly from the dispensing pharmacist.

Q: Is Cloralex ever prescribed to children?

Regulatory documents approve the use of Cloralex as an adjunctive (add-on) treatment for partial seizures in children aged nine years and older. Official regulatory approval for this medication is specifically for adjunctive seizure treatment in children aged nine and older.

Q: Is Cloralex considered a painkiller or an anti-inflammatory?

Cloralex is classified as a benzodiazepine and functions as a Central Nervous System (CNS) depressant. Its approved uses relate to managing anxiety and seizures. It is not classified as a nonsteroidal anti-inflammatory drug (NSAID) or a general analgesic (painkiller).

Q: Is Cloralex the same as its generic version?

Yes. The active ingredient, clorazepate dipotassium, is required by regulatory standards to be the same in both the brand-name (Cloralex) and generic formulations. These generic versions must demonstrate bioequivalence to the brand-name product.

Q: Can Cloralex cause changes in appetite or weight?

Official prescribing information and safety data generally do not list changes in appetite or weight among the common or frequently reported side effects. Information regarding adverse reactions is available in the full prescribing information.

Q: Do side effects from Cloralex go away over time?

Official safety data indicates that the most common Central Nervous System (CNS) depressant effects, such as drowsiness or dizziness, are generally most prominent at the initiation of treatment or following a dosage change. The pattern of effects suggests that these common initial reactions may diminish with continued use.

Q: Does Cloralex interact with common over-the-counter pain relievers?

Regulatory warnings regarding interactions focus primarily on co-use with opioids and other prescription medications classified as CNS depressants. Non-opioid over-the-counter pain relievers are generally not specifically listed in official documents as having major contraindications.

Q: Why does the official document list so many potential drug interactions?

The extensive list of potential drug interactions is primarily linked to the drug’s pharmacological properties. Interactions are a concern because Cloralex is a CNS depressant and its active form is processed and cleared through specific hepatic (liver) enzymes, which can be affected by other medications.

Q: Is Cloralex safe to use during pregnancy or while breastfeeding?

Official regulatory information states that Cloralex is generally not recommended for use during pregnancy, especially late in the third trimester, due to the potential for fetal risk. It is also not recommended while breastfeeding because the drug is excreted in breast milk.

Q: What should I do if I forget to take my Cloralex dose?

Patient information materials generally outline a procedure for a missed dose, often indicating that the dose can be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the prescribed procedure is often to skip the missed dose entirely.

Q: Should Cloralex be taken with food, or can it be taken on an empty stomach?

According to the official administration instructions in the drug labeling, Cloralex can generally be taken with or without food. Official documents do not specify restrictions related to meals in the administration section.

Q: How long does Cloralex stay in your system after stopping it?

Because Cloralex is converted into a long-acting substance, its active metabolite has a long half-life, ranging from 30 to 100 hours. Due to this extended half-life, it may take several days or longer for the drug to be fully cleared from the body.

Q: How is Cloralex different from other similar medicines I've seen advertised?

Cloralex is specifically classified as a benzodiazepine that acts as a prodrug to the long-acting active metabolite, nordiazepam. This classification and specific mechanism of action define its pharmacological profile compared to other medications used for similar conditions.

Q: Why do people sometimes think Cloralex is an antidepressant?

Cloralex is officially classified as a Central Nervous System (CNS) depressant with anxiolytic and sedative properties. This classification means it works differently in the brain than drugs that are specifically designated as antidepressant medications.

Q: Can Cloralex cause insomnia or sleep disturbances?

While drowsiness is a common effect, regulatory documents also list the potential for rare paradoxical reactions. These adverse effects include excitement or agitation, which may result in difficulty sleeping or disturbances in the normal sleep pattern.

Q: Is Cloralex a newly approved medication?

The official documentation provides the date of the original regulatory approval for the active substance, clorazepate dipotassium. This information can be verified in the official drug history documentation, showing that the medication has been available for many years.

How should Cloralex be stored and disposed of?

Storage Conditions

Cloralex (clorazepate dipotassium) tablets must be stored at Controlled Room Temperature (CRT), specifically between 20 C and 25 C (68 F and 77 F). The medication must be kept in its original container, tightly closed, and protected from light and moisture to maintain stability. Storage in high-humidity areas, such as a bathroom, is prohibited.

Child-Safety and Handling

This medication must be kept out of the reach and sight of children. As a Schedule IV controlled substance, it is required to be stored in a safe place to prevent misuse and diversion.

Disposal Instructions

Disposal should prioritize taking the unused or expired medication to a DEA-authorized drug take-back program. If a take-back option is unavailable, the tablets should be mixed with an unappealing substance, sealed in a bag, and discarded in the household trash. It must not be flushed down the toilet or poured into a drain unless specific federal guidelines advise otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cloralex found in:

A-Z Index: